你即將離開本站

並前往https://www.adaptimmune.com/clinical-trials

Clinical Trials :: Adaptimmune Therapeutics plc (ADAP)

SURPASS (ADP-A2M4CD8). This is a Phase 1, open-label, dose escalation clinical trial to evaluate the safety and anti-tumor activity of next-generation ...

確定！ 回上一頁

查詢 「SURPASS study」的人也找了：

  1. SURPASS study
    2.
  2. Tirzepatide
    3.
  3. SURPASS-3 tirzepatide
    4.
  4. SURPASS 4 tirzepatide
    5.
  5. Tirzepatide lancet
    6.
  6. Tirzepatide a potential new agent for type 2 diabetes
    7.
  7. SURPASS-CVOT
    8.
  8. Tirzepatide FDA
    9.